nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—DRD1—attention deficit hyperactivity disorder	0.494	0.647	CbGaD
Methylergometrine—HTR2A—attention deficit hyperactivity disorder	0.269	0.353	CbGaD
Methylergometrine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00699	0.13	CbGeAlD
Methylergometrine—HTR1F—forebrain—attention deficit hyperactivity disorder	0.00439	0.082	CbGeAlD
Methylergometrine—HTR1E—forebrain—attention deficit hyperactivity disorder	0.00381	0.071	CbGeAlD
Methylergometrine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00372	0.0693	CbGeAlD
Methylergometrine—HTR1F—nervous system—attention deficit hyperactivity disorder	0.00239	0.0445	CbGeAlD
Methylergometrine—HTR1F—central nervous system—attention deficit hyperactivity disorder	0.0023	0.0429	CbGeAlD
Methylergometrine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00222	0.0415	CbGeAlD
Methylergometrine—HTR1E—nervous system—attention deficit hyperactivity disorder	0.00207	0.0386	CbGeAlD
Methylergometrine—HTR1E—central nervous system—attention deficit hyperactivity disorder	0.00199	0.0371	CbGeAlD
Methylergometrine—HTR1F—brain—attention deficit hyperactivity disorder	0.00182	0.034	CbGeAlD
Methylergometrine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00173	0.0322	CbGeAlD
Methylergometrine—HTR2B—forebrain—attention deficit hyperactivity disorder	0.00162	0.0303	CbGeAlD
Methylergometrine—HTR1E—brain—attention deficit hyperactivity disorder	0.00158	0.0295	CbGeAlD
Methylergometrine—DRD1—midbrain—attention deficit hyperactivity disorder	0.00147	0.0274	CbGeAlD
Methylergometrine—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.00137	0.0256	CbGeAlD
Methylergometrine—DRD1—nervous system—attention deficit hyperactivity disorder	0.00121	0.0225	CbGeAlD
Methylergometrine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.00116	0.0217	CbGeAlD
Methylergometrine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.00114	0.0213	CbGeAlD
Methylergometrine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000937	0.0175	CbGeAlD
Methylergometrine—DRD1—brain—attention deficit hyperactivity disorder	0.000922	0.0172	CbGeAlD
Methylergometrine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000902	0.0168	CbGeAlD
Methylergometrine—HTR2B—nervous system—attention deficit hyperactivity disorder	0.00088	0.0164	CbGeAlD
Methylergometrine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000866	0.0162	CbGeAlD
Methylergometrine—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000847	0.0158	CbGeAlD
Methylergometrine—Pergolide—DRD5—attention deficit hyperactivity disorder	0.000748	0.0688	CrCbGaD
Methylergometrine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000732	0.0137	CbGeAlD
Methylergometrine—HTR2C—brain—attention deficit hyperactivity disorder	0.000716	0.0134	CbGeAlD
Methylergometrine—Pergolide—ADRA2C—attention deficit hyperactivity disorder	0.000706	0.0649	CrCbGaD
Methylergometrine—HTR2B—brain—attention deficit hyperactivity disorder	0.000673	0.0126	CbGeAlD
Methylergometrine—Lisuride—DRD5—attention deficit hyperactivity disorder	0.000649	0.0597	CrCbGaD
Methylergometrine—Lisuride—ADRA2C—attention deficit hyperactivity disorder	0.000612	0.0563	CrCbGaD
Methylergometrine—Bromocriptine—DRD5—attention deficit hyperactivity disorder	0.000602	0.0553	CrCbGaD
Methylergometrine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000572	0.0107	CbGeAlD
Methylergometrine—Bromocriptine—ADRA2C—attention deficit hyperactivity disorder	0.000567	0.0521	CrCbGaD
Methylergometrine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.00047	0.00877	CbGeAlD
Methylergometrine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000453	0.00845	CbGeAlD
Methylergometrine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000442	0.00825	CbGeAlD
Methylergometrine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000435	0.00812	CbGeAlD
Methylergometrine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000419	0.00782	CbGeAlD
Methylergometrine—Pergolide—DRD4—attention deficit hyperactivity disorder	0.000383	0.0352	CrCbGaD
Methylergometrine—Methysergide—HTR1B—attention deficit hyperactivity disorder	0.000367	0.0338	CrCbGaD
Methylergometrine—HTR2A—brain—attention deficit hyperactivity disorder	0.000359	0.0067	CbGeAlD
Methylergometrine—Pergolide—HTR1B—attention deficit hyperactivity disorder	0.00034	0.0313	CrCbGaD
Methylergometrine—Lisuride—DRD4—attention deficit hyperactivity disorder	0.000332	0.0305	CrCbGaD
Methylergometrine—Pergolide—DRD3—attention deficit hyperactivity disorder	0.00033	0.0303	CrCbGaD
Methylergometrine—Pergolide—DRD1—attention deficit hyperactivity disorder	0.000324	0.0298	CrCbGaD
Methylergometrine—Bromocriptine—DRD4—attention deficit hyperactivity disorder	0.000308	0.0283	CrCbGaD
Methylergometrine—Pergolide—ADRA2A—attention deficit hyperactivity disorder	0.000301	0.0277	CrCbGaD
Methylergometrine—Lisuride—HTR1B—attention deficit hyperactivity disorder	0.000295	0.0271	CrCbGaD
Methylergometrine—Lisuride—DRD3—attention deficit hyperactivity disorder	0.000286	0.0263	CrCbGaD
Methylergometrine—Ergotamine—HTR1B—attention deficit hyperactivity disorder	0.000283	0.0261	CrCbGaD
Methylergometrine—Lisuride—DRD1—attention deficit hyperactivity disorder	0.000281	0.0258	CrCbGaD
Methylergometrine—Bromocriptine—HTR1B—attention deficit hyperactivity disorder	0.000273	0.0251	CrCbGaD
Methylergometrine—Bromocriptine—DRD3—attention deficit hyperactivity disorder	0.000265	0.0244	CrCbGaD
Methylergometrine—Lisuride—ADRA2A—attention deficit hyperactivity disorder	0.000261	0.024	CrCbGaD
Methylergometrine—Bromocriptine—DRD1—attention deficit hyperactivity disorder	0.00026	0.0239	CrCbGaD
Methylergometrine—Ergotamine—ADRA2A—attention deficit hyperactivity disorder	0.000251	0.0231	CrCbGaD
Methylergometrine—Bromocriptine—ADRA2A—attention deficit hyperactivity disorder	0.000242	0.0223	CrCbGaD
Methylergometrine—Pergolide—DRD2—attention deficit hyperactivity disorder	0.000228	0.021	CrCbGaD
Methylergometrine—Lisuride—DRD2—attention deficit hyperactivity disorder	0.000198	0.0182	CrCbGaD
Methylergometrine—Methysergide—HTR2A—attention deficit hyperactivity disorder	0.000191	0.0175	CrCbGaD
Methylergometrine—Ergotamine—DRD2—attention deficit hyperactivity disorder	0.00019	0.0175	CrCbGaD
Methylergometrine—Bromocriptine—DRD2—attention deficit hyperactivity disorder	0.000184	0.0169	CrCbGaD
Methylergometrine—Pergolide—HTR2A—attention deficit hyperactivity disorder	0.000176	0.0162	CrCbGaD
Methylergometrine—Lisuride—HTR2A—attention deficit hyperactivity disorder	0.000153	0.0141	CrCbGaD
Methylergometrine—Ergotamine—HTR2A—attention deficit hyperactivity disorder	0.000147	0.0135	CrCbGaD
Methylergometrine—Bromocriptine—HTR2A—attention deficit hyperactivity disorder	0.000142	0.013	CrCbGaD
Methylergometrine—HTR1F—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	9.23e-05	0.000536	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.16e-05	0.000533	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	9.16e-05	0.000532	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	9.14e-05	0.000532	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	9.13e-05	0.000531	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	9.06e-05	0.000527	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	9.04e-05	0.000526	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.01e-05	0.000524	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9e-05	0.000524	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.96e-05	0.000521	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.93e-05	0.000519	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.89e-05	0.000517	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.86e-05	0.000515	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	8.83e-05	0.000514	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	8.78e-05	0.000511	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	8.76e-05	0.000509	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	8.7e-05	0.000506	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	8.67e-05	0.000504	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.65e-05	0.000503	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.62e-05	0.000501	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	8.58e-05	0.000499	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.5e-05	0.000494	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.45e-05	0.000491	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	8.4e-05	0.000488	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8.39e-05	0.000488	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	8.39e-05	0.000488	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	8.38e-05	0.000487	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.34e-05	0.000485	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8.31e-05	0.000483	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.3e-05	0.000483	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	8.28e-05	0.000482	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.21e-05	0.000478	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.17e-05	0.000475	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.17e-05	0.000475	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.15e-05	0.000474	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.13e-05	0.000473	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	8.09e-05	0.00047	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.06e-05	0.000469	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.01e-05	0.000466	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.01e-05	0.000466	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	7.95e-05	0.000463	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.92e-05	0.00046	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.92e-05	0.00046	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	7.9e-05	0.00046	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.87e-05	0.000457	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7.84e-05	0.000456	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	7.84e-05	0.000456	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.83e-05	0.000455	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.82e-05	0.000455	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	7.82e-05	0.000455	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	7.79e-05	0.000453	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.75e-05	0.00045	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.72e-05	0.000449	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.71e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.7e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.7e-05	0.000448	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.67e-05	0.000446	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	7.61e-05	0.000442	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.56e-05	0.000439	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.54e-05	0.000439	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.51e-05	0.000437	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.41e-05	0.000431	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.38e-05	0.000429	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.37e-05	0.000429	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	7.35e-05	0.000427	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.32e-05	0.000426	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.31e-05	0.000425	CbGpPWpGaD
Methylergometrine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	7.28e-05	0.000423	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.23e-05	0.00042	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.2e-05	0.000419	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.19e-05	0.000418	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.19e-05	0.000418	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.12e-05	0.000414	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.09e-05	0.000412	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.99e-05	0.000407	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.98e-05	0.000406	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.91e-05	0.000402	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.9e-05	0.000401	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.86e-05	0.000399	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.82e-05	0.000397	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.78e-05	0.000394	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.77e-05	0.000394	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.77e-05	0.000394	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.73e-05	0.000391	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.7e-05	0.000389	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.56e-05	0.000382	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.44e-05	0.000374	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.41e-05	0.000372	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.31e-05	0.000367	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.28e-05	0.000365	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.25e-05	0.000364	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.21e-05	0.000361	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.06e-05	0.000352	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.95e-05	0.000346	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.9e-05	0.000343	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.88e-05	0.000342	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.86e-05	0.00034	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.82e-05	0.000338	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.8e-05	0.000337	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.71e-05	0.000332	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.7e-05	0.000331	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.66e-05	0.000329	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.64e-05	0.000328	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.48e-05	0.000319	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.48e-05	0.000318	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.43e-05	0.000316	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.38e-05	0.000313	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.34e-05	0.000311	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.32e-05	0.000309	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.26e-05	0.000306	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.16e-05	0.0003	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.12e-05	0.000298	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.12e-05	0.000298	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.12e-05	0.000298	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.05e-05	0.000293	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.01e-05	0.000291	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.96e-05	0.000289	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.95e-05	0.000288	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.93e-05	0.000287	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.9e-05	0.000285	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.89e-05	0.000284	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.81e-05	0.000279	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.8e-05	0.000279	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.78e-05	0.000278	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.74e-05	0.000276	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.71e-05	0.000274	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.67e-05	0.000271	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.66e-05	0.000271	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.65e-05	0.00027	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.63e-05	0.000269	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.61e-05	0.000268	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.61e-05	0.000268	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.6e-05	0.000268	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.58e-05	0.000266	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.55e-05	0.000264	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.53e-05	0.000263	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.53e-05	0.000263	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.51e-05	0.000262	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.47e-05	0.00026	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.46e-05	0.000259	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.44e-05	0.000258	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.44e-05	0.000258	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.42e-05	0.000257	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.42e-05	0.000257	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.38e-05	0.000255	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.38e-05	0.000255	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.36e-05	0.000254	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.35e-05	0.000253	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.34e-05	0.000252	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.33e-05	0.000252	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.31e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.2e-05	0.000244	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.18e-05	0.000243	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.17e-05	0.000242	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.13e-05	0.00024	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.11e-05	0.000239	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.08e-05	0.000237	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.07e-05	0.000237	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.06e-05	0.000236	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.03e-05	0.000234	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.01e-05	0.000233	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4e-05	0.000233	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.98e-05	0.000231	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.96e-05	0.00023	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.95e-05	0.00023	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.94e-05	0.000229	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.89e-05	0.000226	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.88e-05	0.000225	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.87e-05	0.000225	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.87e-05	0.000225	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.84e-05	0.000223	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.83e-05	0.000223	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.8e-05	0.000221	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.8e-05	0.000221	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.8e-05	0.000221	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.78e-05	0.00022	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.7e-05	0.000215	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.58e-05	0.000208	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.57e-05	0.000207	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.53e-05	0.000206	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.52e-05	0.000205	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.48e-05	0.000202	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.45e-05	0.000201	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.44e-05	0.0002	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.42e-05	0.000199	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.37e-05	0.000196	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.36e-05	0.000196	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.33e-05	0.000194	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.32e-05	0.000193	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.3e-05	0.000192	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.24e-05	0.000188	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.21e-05	0.000187	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.14e-05	0.000183	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.11e-05	0.000181	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.1e-05	0.00018	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.09e-05	0.00018	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.06e-05	0.000178	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.02e-05	0.000175	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.92e-05	0.00017	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.91e-05	0.000169	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.82e-05	0.000164	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.81e-05	0.000163	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.81e-05	0.000163	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.75e-05	0.00016	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.71e-05	0.000157	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.69e-05	0.000156	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.66e-05	0.000155	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.65e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.62e-05	0.000152	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.58e-05	0.00015	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.54e-05	0.000148	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.5e-05	0.000145	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.47e-05	0.000144	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.43e-05	0.000141	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.4e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.37e-05	0.000138	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.35e-05	0.000137	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.33e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.27e-05	0.000132	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.24e-05	0.00013	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.18e-05	0.000127	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.11e-05	0.000123	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.08e-05	0.000121	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.05e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.04e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.91e-05	0.000111	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.9e-05	0.00011	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.84e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.81e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.78e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.66e-05	9.66e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.66e-05	9.65e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.59e-05	9.26e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.57e-05	9.1e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.5e-05	8.7e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.41e-05	8.2e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.34e-05	7.79e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.1e-05	6.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.1e-05	6.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.08e-05	6.29e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.01e-05	5.85e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.8e-06	5.11e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.79e-06	5.11e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.37e-06	4.87e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.3e-06	4.82e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.1e-06	4.13e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.66e-06	3.87e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.61e-06	3.85e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.16e-06	3.58e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.86e-06	1.66e-05	CbGpPWpGaD
